DA
DCF Advisers Portfolio holdings
AUM
$208M
1-Year Return
21.52%
This Quarter Return
+9.93%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$148M
AUM Growth
+$4.28M
(+3%)
Cap. Flow
-$9.28M
Cap. Flow
% of AUM
-6.29%
Top 10 Holdings %
Top 10 Hldgs %
49.62%
Holding
88
New
3
Increased
17
Reduced
30
Closed
9
Top Buys
| 1 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
$2.02M |
| 2 |
Alibaba
BABA
|
$1.28M |
| 3 |
Regeneron Pharmaceuticals
REGN
|
$1.16M |
| 4 |
Lifecore Biomedical
LFCR
|
$860K |
| 5 |
Yeti Holdings
YETI
|
$518K |
Top Sells
| 1 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$2.33M |
| 2 |
AbbVie
ABBV
|
$1.86M |
| 3 |
VanEck Junior Gold Miners ETF
GDXJ
|
$1.38M |
| 4 |
AT&T
T
|
$1.07M |
| 5 |
SPDR S&P Biotech ETF
XBI
|
$986K |
Sector Composition
| 1 | Healthcare | 39.95% |
| 2 | Technology | 21.46% |
| 3 | Communication Services | 8.48% |
| 4 | Consumer Discretionary | 5.11% |
| 5 | Financials | 4.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Yeti Holdings
YETI
$2.9B
| $518K | 0.28% |
+10,000
| New | +$518K |
|
52
iShares MSCI Emerging Markets ETF
EEM
$18.9B
| $503K | 0.27% |
12,500
| – | – |
|
|
IMGN
53
DELISTED
Immunogen Inc
IMGN
| $415K | 0.23% |
14,000
+1,150
| +9% | +$34.1K |
|
54
Teva Pharmaceuticals
TEVA
$21.3B
| $407K | 0.22% |
39,000
-5,500
| -12% | -$57.4K |
|
55
Lam Research
LRCX
$126B
| $392K | 0.21% |
5,000
| – | – |
|
56
Spotify
SPOT
$144B
| $376K | 0.2% |
2,000
| – | – |
|
57
Citigroup
C
$178B
| $373K | 0.2% |
7,250
| – | – |
|
58
Wolfspeed
WOLF
$196M
| $326K | 0.18% |
7,500
-6,500
| -46% | -$283K |
|
59
Alnylam Pharmaceuticals
ALNY
$59.5B
| $249K | 0.14% |
1,300
-500
| -28% | -$95.7K |
|
60
Johnson & Johnson
JNJ
$429B
| $235K | 0.13% |
1,500
| – | – |
|
61
Roblox
RBLX
$90.8B
| $229K | 0.12% |
+5,000
| New | +$229K |
|
62
Viridian Therapeutics
VRDN
$1.55B
| $207K | 0.11% |
9,500
-4,000
| -30% | -$87.1K |
|
63
Nokia
NOK
$24.6B
| $171K | 0.09% |
50,000
-121,500
| -71% | -$416K |
|
64
Lineage Cell Therapeutics
LCTX
$276M
| $103K | 0.06% |
94,751
+12,000
| +15% | +$13.1K |
|
|
TBHC
65
The Brand House Collective, Inc. Common Stock
TBHC
$33M
| $76.8K | 0.04% |
25,415
-9,820
| -28% | -$29.7K |
|
66
Ovid Therapeutics
OVID
$93.9M
| $60.3K | 0.03% |
18,730
-11,700
| -38% | -$37.7K |
|
67
United States Natural Gas Fund
UNG
$616M
| $58.3K | 0.03% |
2,875
-875
| -23% | -$17.7K |
|
68
Arq
ARQ
$311M
| $40.2K | 0.02% |
+13,496
| New | +$40.2K |
|
|
AMRN
69
Amarin Corp
AMRN
$307M
| $11.6K | 0.01% |
665
-40
| -6% | -$695 |
|
70
Air T
AIRT
| – | – |
-9,135
| Closed | -$204K |
|
71
Amazon
AMZN
$2.48T
| – | – |
-5,000
| Closed | -$636K |
|
72
Baidu
BIDU
$33.6B
| – | – |
0
| – | – |
|
73
Bristol-Myers Squibb
BMY
$96B
| – | – |
-5,250
| Closed | -$305K |
|
74
Equillium
EQ
$64.7M
| – | – |
-69,871
| Closed | -$51.7K |
|
75
iShares China Large-Cap ETF
FXI
$6.53B
| – | – |
0
| – | – |
|